Bergen New Bridge Medical Center is the first in the state to offer post-vaccine antibody testing for the SARS-CoV-2 IgG Spike protein, the facility announced April 12.
This COVID-19 antibody testing uses the Abbott platform to help physicians recognize vaccine generated immunity versus autoimmunity from prior infection in their patients, according to an announcement, and is part of Bergen New Bridge‘s ongoing effort to expand its scope of services.
“I am proud to continue to lead the way in COVID-19 mitigation and management”, said Bergen New Bridge Medical Center President and Chief Executive Officer Deborah Visconi in a prepared statement.
“As we work toward achieving community immunity, this test will become an essential weapon in our COVID-19 arsenal so those who have had the virus or received the vaccine, can begin to understand and gauge their levels of immunity. This information will be essential to track our continued virus protection as we emerge from this pandemic,” Visconi said.